XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment Jun 06, 2009 5:20pm EDT
XOMA Announces Clinical and Preclinical Presentations At American Diabetes Association 69th Scientific Sessions May 26, 2009 11:55am EDT
XOMA Royalties On CIMZIA(r) Expected to Increase Due to FDA Approval for Moderate to Severe Rheumatoid Arthritis in Adults May 14, 2009 3:25pm EDT
XOMA to Present At Canaccord Adams Diabetes & Obesity Conference on May 12, 2009 May 05, 2009 9:00am EDT
XOMA to Announce First Quarter 2009 Financial Results and Host Conference Call On May 7 May 01, 2009 12:11pm EDT
